Skip to content

Advertisement

Open Peer Review Reports for: A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
2 Aug 2016 Submitted Original manuscript
3 Oct 2016 Reviewed Reviewer Report - John McAuliffe
19 Oct 2016 Reviewed Reviewer Report - Motoyoshi Tanaka
17 Nov 2016 Author responded Author comments - Berta Laquente
Resubmission - Version 2
17 Nov 2016 Submitted Manuscript version 2
15 Dec 2016 Author responded Author comments - Berta Laquente
Resubmission - Version 3
15 Dec 2016 Submitted Manuscript version 3
20 Jan 2017 Author responded Author comments - Berta Laquente
Resubmission - Version 4
20 Jan 2017 Submitted Manuscript version 4
6 Feb 2017 Author responded Author comments - Berta Laquente
Resubmission - Version 5
6 Feb 2017 Submitted Manuscript version 5
Publishing
9 Feb 2017 Editorially accepted
15 Feb 2017 Article published 10.1186/s12885-017-3131-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement